CFMS Stock Price, Chart, Stats & News
Conformis, Inc. (CFMS) does not currently pay a dividend.
CFMS chart
Fundamentals
Gross margin | 37.41% |
Operating margin | -74.58% |
Pretax margin | -81.38% |
Net margin | -81.34% |
Effective tax rate | 0.05% |
ROA | -53.67% |
ROE | -65.24% |
D/E | 0.51x |
Interest coverage ratio | -22.92x |
CFMS valuation
P/E | – |
P/S | 0.29x |
P/B | 0.30x |
P/CF | -0.33x |
P/FCF | -0.34x |
P/OCF | -0.33x |
PEG | -0.00x |
EV multiple | -0.81x |
About
Conformis, Inc., established in Billerica, Massachusetts in 2004, functions as a medical technology enterprise that designs, produces, and commercializes custom-fit medical devices and surgical instruments. Their product portfolio encompasses a variety of personalized knee replacement systems, including iUni and iDuo for addressing unicompartmental or bicompartmental knee osteoarthritis, the iTotal CR for cruciate-retaining total knee procedures, the iTotal PS for posterior-stabilized total knee replacements, as well as the iTotal Identity and Identity Imprint lines. Additionally, the company offers hip replacement options like the Conformis Hip System and Cordera products, and provides iJigs, which are personalized, single-use surgical guides.
Similar securities
Based on sector and market capitalization
